Newsletter of COMPAMED | View in browser | Deutsch | Print
Image: Header picture of COMPAMED Newsletter

Automated production of mRNA therapeutics

Dear Sir or Madam,

The Fraunhofer lighthouse project RNAuto aims to automate the production of mRNA therapeutics in order to manufacture cancer drugs more cost-effectively and economically. Led by Rolf Hendrik van Lengen from Fraunhofer IESE, the project promises to drastically reduce production costs through the use of modular systems, digital quality control and artificial intelligence. With the involvement of seven Fraunhofer Institutes, RNAuto is scheduled for completion by the end of 2025, representing a significant step towards affordable therapies. Find out more about this initiative in our interview with Mr. van Lengen.

Discover the most exciting news in medical technology in the COMPAMED magazine!

We hope you enjoy exploring our content and wish you an inspiring week

Tim Plato
Editorial team COMPAMED-tradefair.com

Content
Interview: Automated production of mRNA therapeutics
Stay informed at COMPAMED-tradefair.com
Newsletter Service

Automated production of mRNA therapeutics

Interview - IT IN TECH
Image: Graphic representation of the encapsulation of the mRNA active ingredient in the automated screening system as part of the RNAuto research project; Copyright: Fraunhofer IESE
The price of a drug is not only dependent on the raw materials used, but is also determined by the manufacturing process. High prices are charged for some cancer drugs in particular, as they can only be produced in small quantities at great expense. Keyword: mRNA therapeutics.
Read more in the interview!
Automated production of mRNA therapeutics
All content around IT IN TECH at COMPAMED-tradefair.com
To top
Image: Banner with the text: COMPAMED Magazine - 365 days a year; Copyright: Messe Düsseldorf

Photoacoustic sensing instrument for tissue diagniostics

News

MANUFACTURING & DEVICES
In the pursuit of enhancing clinical diagnostics, researchers at the Indian Institute of Technology Indore have unveiled a new tool—a compact and cost-effective photoacoustic (PA) sensing instrument designed for biomedical tissue diagnosis. This development improves diagnostic practices, patient care and outcomes, offering rapid and accurate insights into breast tissue characterization.
read more
To top

Advancements in all-solid-state batteries by KIST-LLNL collaboration

News

MANUFACTURING & DEVICES
Researchers from the Korea Institute of Science and Technology (KIST) and Lawrence Livermore National Laboratory (LLNL) have made significant progress in developing high-energy-density all-solid-state batteries, aiming for commercialization. Their latest research focuses on the design and synthesis of stable solid electrolytes, crucial for safer and more efficient lithium battery technology.
read more
To top

New technology for brain cancer visualization

News

MANUFACTURING & DEVICES
Researchers from Brigham and Women's Hospital and the Massachusetts Institute of Technology (MIT) have developed a groundbreaking microscopy technology known as decrowding expansion pathology (dExPath). This innovative method allows for the visualization of previously unseen details in human brain tissue, opening new avenues for the diagnosis and treatment of brain cancer.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.COMPAMED.de/news_abo_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@compamed.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook X LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.